PubMed

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.

Nelson HD, Huffman LH, Fu R, Harris EL; U.S. Preventive Services Task Force.

Ann Intern Med. 2005 Sep 6;143(5):362-79. Review. Erratum in: Ann Intern Med. 2005 Oct 4;143(7):547. PMID: 16144895 [PubMed - indexed for MEDLINE]Related articlesFree article

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.

U.S. Preventive Services Task Force.

Ann Intern Med. 2005 Sep 6;143(5):355-61. Review. Erratum in: Ann Intern Med. 2005 Oct 4;143(7):547. PMID: 16144894 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: U.S. Preventive Services Task Force recommendations.

[No authors listed]

Ann Intern Med. 2005 Sep 6;143(5):I47. No abstract available. PMID: 16144889 [PubMed - indexed for MEDLINE]Related articlesFree article

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.

Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P, McTiernan A, Offit K, Perlman J, Petersen G, Thomson E, Varricchio C.

JAMA. 1997 Mar 26;277(12):997-1003. Review.PMID: 9091675 [PubMed - indexed for MEDLINE]Related articles

[Clinical and molecular diagnosis of inherited breast-ovarian cancer]

Chompret A.

J Gynecol Obstet Biol Reprod (Paris). 2003 Apr;32(2):101-19. Review. French. PMID: 12717301 [PubMed - indexed for MEDLINE]Related articlesFree article

Testing for hereditary breast and ovarian cancer in the southeastern United States.

Miron A, Schildkraut JM, Rimer BK, Winer EP, Sugg Skinner C, Futreal PA, Culler D, Calingaert B, Clark S, Kelly Marcom P, Iglehart JD.

Ann Surg. 2000 May;231(5):624-34.PMID: 10767783 [PubMed - indexed for MEDLINE]Related articlesFree article

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.

Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM.

J Natl Cancer Inst. 1997 Jan 15;89(2):148-57.PMID: 8998184 [PubMed - indexed for MEDLINE]Related articlesFree article

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.

Armstrong K, Micco E, Carney A, Stopfer J, Putt M.

JAMA. 2005 Apr 13;293(14):1729-36.PMID: 15827311 [PubMed - indexed for MEDLINE]Related articlesFree article

Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.

Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT.

Gynecol Oncol. 2005 May;97(2):457-67.PMID: 15863145 [PubMed - indexed for MEDLINE]Related articles

The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.

Milne RL, Osorio A, Cajal TR, Vega A, Llort G, de la Hoya M, Díez O, Alonso MC, Lazaro C, Blanco I, Sánchez-de-Abajo A, Caldés T, Blanco A, Graña B, Durán M, Velasco E, Chirivella I, Cardeñosa EE, Tejada MI, Beristain E, Miramar MD, Calvo MT, Martínez E, Guillén C, Salazar R, San Román C, Antoniou AC, Urioste M, Benítez J.

Clin Cancer Res. 2008 May 1;14(9):2861-9.PMID: 18451254 [PubMed - indexed for MEDLINE]Related articlesFree article

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.

Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L, Arun B.

Cancer. 2006 Dec 15;107(12):2745-51.PMID: 17109443 [PubMed - indexed for MEDLINE]Related articlesFree article

Prophylactic mastectomy for the prevention of breast cancer.

Lostumbo L, Carbine N, Wallace J, Ezzo J.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD002748. Review.PMID: 15495033 [PubMed - indexed for MEDLINE]Related articles

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J, Ellis N, Hensley M, Boyd J, Borgen P, Norton L, Offit K.

J Clin Oncol. 2002 Mar 1;20(5):1260-8.PMID: 11870168 [PubMed - indexed for MEDLINE]Related articles

Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene.

Finch A, Metcalfe K, Lui J, Springate C, Demsky R, Armel S, Rosen B, Murphy J, Elit L, Sun P, Narod S.

Clin Genet. 2009 Mar;75(3):220-4.PMID: 19263514 [PubMed - indexed for MEDLINE]Related articles

BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian.

Friedenson B.

MedGenMed. 2005 Jun 29;7(2):60.PMID: 16369438 [PubMed - indexed for MEDLINE]Related articlesFree article

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.PMID: 16218901 [PubMed - indexed for MEDLINE]Related articles

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.

Kauff ND, Domchek SM, Friebel TM, Robson ME, Lee J, Garber JE, Isaacs C, Evans DG, Lynch H, Eeles RA, Neuhausen SL, Daly MB, Matloff E, Blum JL, Sabbatini P, Barakat RR, Hudis C, Norton L, Offit K, Rebbeck TR.

J Clin Oncol. 2008 Mar 10;26(8):1331-7. Epub 2008 Feb 11.PMID: 18268356 [PubMed - indexed for MEDLINE]Related articles

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.

Berry DA, Iversen ES Jr, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G.

J Clin Oncol. 2002 Jun 1;20(11):2701-12.PMID: 12039933 [PubMed - indexed for MEDLINE]Related articles

Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.

Kuschel B, Lux MP, Goecke TO, Beckmann MW.

Eur J Cancer Prev. 2000 Jun;9(3):139-50. Review.PMID: 10954253 [PubMed - indexed for MEDLINE]Related articles

Management options after prophylactic surgeries in women with BRCA mutations: a review.

Allain DC, Sweet K, Agnese DM.

Cancer Control. 2007 Oct;14(4):330-7. Review.PMID: 17914333 [PubMed - indexed for MEDLINE]Related articlesFree article